Mutant p53 R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells

I. Kogan-Sakin, Y. Tabach, Y. Buganim, A. Molchadsky, H. Solomon, S. Madar, I. Kamer, P. Stambolsky, A. Shelly, N. Goldfinger, S. Valsesia-Wittmann, A. Puisieux, A. Zundelevich, Einav Nili Gal-Yam, C. Avivi, I. Barshack, M. Brait, D. Sidransky, E. Domany, V. Rotter

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

A mutation within one allele of the p53 tumor suppressor gene can inactivate the remaining wild-type allele in a dominant-negative manner and in some cases can exert an additional oncogenic activity, known as mutant p53 gain of function (GOF). To study the role of p53 mutations in prostate cancer and to discriminate between the dominant-negative effect and the GOF activity of mutant p53, we measured, using microarrays, the expression profiles of three immortalized prostate epithelial cultures expressing wild-type, inactivated p53 or mutated p53. Analysis of these gene expression profiles showed that both inactivated p53 and p53 R175H mutant expression resulted in the upregulation of cell cycle progression genes. A second group, which was upregulated exclusively by mutant p53 R175H, was predominantly enriched in developmental genes. This group of genes included the Twist1, a regulator of metastasis and epithelial-mesenchymal transition (EMT). Twist1 levels were also elevated in metastatic prostate cancer-derived cell line DU145, in immortalized lung fibroblasts and in a subset of lung cancer samples, all in a mutant p53-dependent manner. p53 R175H mutant bearing immortalized epithelial cells showed typical features of EMT, such as higher expression of mesenchymal markers, lower expression of epithelial markers and enhanced invasive properties in vitro. The mechanism by which p53 R175H mutant induces Twist1 expression involves alleviation of the epigenetic repression. Our data suggest that Twist1 expression might be upregulated following p53 mutation in cancer cells.

Original languageEnglish (US)
Pages (from-to)271-281
Number of pages11
JournalCell death and differentiation
Volume18
Issue number2
DOIs
StatePublished - Feb 1 2011

Fingerprint

Epithelial-Mesenchymal Transition
Prostate
Up-Regulation
Mutation
Epigenetic Repression
Prostatic Neoplasms
Alleles
Developmental Genes
cdc Genes
Tumor Suppressor Genes
Transcriptome
Lung Neoplasms
Fibroblasts
Epithelial Cells
Neoplasm Metastasis
Cell Line
Lung
Genes
Neoplasms

Keywords

  • Twist1
  • p53
  • prostate

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Mutant p53 R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells. / Kogan-Sakin, I.; Tabach, Y.; Buganim, Y.; Molchadsky, A.; Solomon, H.; Madar, S.; Kamer, I.; Stambolsky, P.; Shelly, A.; Goldfinger, N.; Valsesia-Wittmann, S.; Puisieux, A.; Zundelevich, A.; Nili Gal-Yam, Einav; Avivi, C.; Barshack, I.; Brait, M.; Sidransky, D.; Domany, E.; Rotter, V.

In: Cell death and differentiation, Vol. 18, No. 2, 01.02.2011, p. 271-281.

Research output: Contribution to journalArticle

Kogan-Sakin, I, Tabach, Y, Buganim, Y, Molchadsky, A, Solomon, H, Madar, S, Kamer, I, Stambolsky, P, Shelly, A, Goldfinger, N, Valsesia-Wittmann, S, Puisieux, A, Zundelevich, A, Nili Gal-Yam, E, Avivi, C, Barshack, I, Brait, M, Sidransky, D, Domany, E & Rotter, V 2011, 'Mutant p53 R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells', Cell death and differentiation, vol. 18, no. 2, pp. 271-281. https://doi.org/10.1038/cdd.2010.94
Kogan-Sakin, I. ; Tabach, Y. ; Buganim, Y. ; Molchadsky, A. ; Solomon, H. ; Madar, S. ; Kamer, I. ; Stambolsky, P. ; Shelly, A. ; Goldfinger, N. ; Valsesia-Wittmann, S. ; Puisieux, A. ; Zundelevich, A. ; Nili Gal-Yam, Einav ; Avivi, C. ; Barshack, I. ; Brait, M. ; Sidransky, D. ; Domany, E. ; Rotter, V. / Mutant p53 R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells. In: Cell death and differentiation. 2011 ; Vol. 18, No. 2. pp. 271-281.
@article{7cd5fae6ea4d4100a4dab16fab14ce5c,
title = "Mutant p53 R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells",
abstract = "A mutation within one allele of the p53 tumor suppressor gene can inactivate the remaining wild-type allele in a dominant-negative manner and in some cases can exert an additional oncogenic activity, known as mutant p53 gain of function (GOF). To study the role of p53 mutations in prostate cancer and to discriminate between the dominant-negative effect and the GOF activity of mutant p53, we measured, using microarrays, the expression profiles of three immortalized prostate epithelial cultures expressing wild-type, inactivated p53 or mutated p53. Analysis of these gene expression profiles showed that both inactivated p53 and p53 R175H mutant expression resulted in the upregulation of cell cycle progression genes. A second group, which was upregulated exclusively by mutant p53 R175H, was predominantly enriched in developmental genes. This group of genes included the Twist1, a regulator of metastasis and epithelial-mesenchymal transition (EMT). Twist1 levels were also elevated in metastatic prostate cancer-derived cell line DU145, in immortalized lung fibroblasts and in a subset of lung cancer samples, all in a mutant p53-dependent manner. p53 R175H mutant bearing immortalized epithelial cells showed typical features of EMT, such as higher expression of mesenchymal markers, lower expression of epithelial markers and enhanced invasive properties in vitro. The mechanism by which p53 R175H mutant induces Twist1 expression involves alleviation of the epigenetic repression. Our data suggest that Twist1 expression might be upregulated following p53 mutation in cancer cells.",
keywords = "Twist1, p53, prostate",
author = "I. Kogan-Sakin and Y. Tabach and Y. Buganim and A. Molchadsky and H. Solomon and S. Madar and I. Kamer and P. Stambolsky and A. Shelly and N. Goldfinger and S. Valsesia-Wittmann and A. Puisieux and A. Zundelevich and {Nili Gal-Yam}, Einav and C. Avivi and I. Barshack and M. Brait and D. Sidransky and E. Domany and V. Rotter",
year = "2011",
month = "2",
day = "1",
doi = "10.1038/cdd.2010.94",
language = "English (US)",
volume = "18",
pages = "271--281",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Mutant p53 R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells

AU - Kogan-Sakin, I.

AU - Tabach, Y.

AU - Buganim, Y.

AU - Molchadsky, A.

AU - Solomon, H.

AU - Madar, S.

AU - Kamer, I.

AU - Stambolsky, P.

AU - Shelly, A.

AU - Goldfinger, N.

AU - Valsesia-Wittmann, S.

AU - Puisieux, A.

AU - Zundelevich, A.

AU - Nili Gal-Yam, Einav

AU - Avivi, C.

AU - Barshack, I.

AU - Brait, M.

AU - Sidransky, D.

AU - Domany, E.

AU - Rotter, V.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - A mutation within one allele of the p53 tumor suppressor gene can inactivate the remaining wild-type allele in a dominant-negative manner and in some cases can exert an additional oncogenic activity, known as mutant p53 gain of function (GOF). To study the role of p53 mutations in prostate cancer and to discriminate between the dominant-negative effect and the GOF activity of mutant p53, we measured, using microarrays, the expression profiles of three immortalized prostate epithelial cultures expressing wild-type, inactivated p53 or mutated p53. Analysis of these gene expression profiles showed that both inactivated p53 and p53 R175H mutant expression resulted in the upregulation of cell cycle progression genes. A second group, which was upregulated exclusively by mutant p53 R175H, was predominantly enriched in developmental genes. This group of genes included the Twist1, a regulator of metastasis and epithelial-mesenchymal transition (EMT). Twist1 levels were also elevated in metastatic prostate cancer-derived cell line DU145, in immortalized lung fibroblasts and in a subset of lung cancer samples, all in a mutant p53-dependent manner. p53 R175H mutant bearing immortalized epithelial cells showed typical features of EMT, such as higher expression of mesenchymal markers, lower expression of epithelial markers and enhanced invasive properties in vitro. The mechanism by which p53 R175H mutant induces Twist1 expression involves alleviation of the epigenetic repression. Our data suggest that Twist1 expression might be upregulated following p53 mutation in cancer cells.

AB - A mutation within one allele of the p53 tumor suppressor gene can inactivate the remaining wild-type allele in a dominant-negative manner and in some cases can exert an additional oncogenic activity, known as mutant p53 gain of function (GOF). To study the role of p53 mutations in prostate cancer and to discriminate between the dominant-negative effect and the GOF activity of mutant p53, we measured, using microarrays, the expression profiles of three immortalized prostate epithelial cultures expressing wild-type, inactivated p53 or mutated p53. Analysis of these gene expression profiles showed that both inactivated p53 and p53 R175H mutant expression resulted in the upregulation of cell cycle progression genes. A second group, which was upregulated exclusively by mutant p53 R175H, was predominantly enriched in developmental genes. This group of genes included the Twist1, a regulator of metastasis and epithelial-mesenchymal transition (EMT). Twist1 levels were also elevated in metastatic prostate cancer-derived cell line DU145, in immortalized lung fibroblasts and in a subset of lung cancer samples, all in a mutant p53-dependent manner. p53 R175H mutant bearing immortalized epithelial cells showed typical features of EMT, such as higher expression of mesenchymal markers, lower expression of epithelial markers and enhanced invasive properties in vitro. The mechanism by which p53 R175H mutant induces Twist1 expression involves alleviation of the epigenetic repression. Our data suggest that Twist1 expression might be upregulated following p53 mutation in cancer cells.

KW - Twist1

KW - p53

KW - prostate

UR - http://www.scopus.com/inward/record.url?scp=78651289008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651289008&partnerID=8YFLogxK

U2 - 10.1038/cdd.2010.94

DO - 10.1038/cdd.2010.94

M3 - Article

C2 - 20689556

AN - SCOPUS:78651289008

VL - 18

SP - 271

EP - 281

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 2

ER -